Harnessing AI for Breakthroughs in Pharma and Biotech

The Sixth Sense of CX with NICE ENLIGHTEN

The latest artificial intelligence (AI)  and machine learning (ML) methods are transforming the research and development process within drug discovery, delivering on the promise to accelerate the journey from laboratory insights to lifesaving therapies. But AI techniques aren’t enough on their own; AI is only as powerful as the data it consumes, and it works best with data that has the proper quality, detail, and context. While there is abundant scientific data in pharmaceuticals and biotechnology, it is often siloed, poorly modeled, and ultimately inaccessible. A meticulous approach to capturing and curating R&D data is indispensable to unlock the full potential of novel AI methodologies.




This white paper explains how optimizing data management – the ingestion, storage, organization, and maintenance of data – helps leaders in drug discovery leverage AI in their mission to deliver innovative drugs to patients in need.

Download the whitepaper to learn more

By submitting my personal data, I acknowledge that Revvity, Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy (available here).

By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order to receive communications regarding Revvity Signals products, services, and events. The data sent will be processed in Canada and provided to Revvity Signals who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal.